Skip to main content
. Author manuscript; available in PMC: 2017 Jun 23.
Published in final edited form as: Prog Mol Biol Transl Sci. 2013;115:1–59. doi: 10.1016/B978-0-12-394587-7.00001-4

Figure 1.2.

Figure 1.2

Allosteric ligands can show a range of efficacies as modulators of agonist activity. Displayed are CRCs for hypothetical compounds “A” and “B” that act at a Gs-coupled receptor. (A) One of the standard assays for measuring activity of Gs-coupled receptors is the accumulation of cAMP, and for these compounds, A appears to be a robust PAM at this receptor while compound B appears to be essentially inactive. However, in a β-arrestin recruitment assay (B), both compounds robustly potentiate the agonist’s recruitment of β-arrestin to the receptor, indicating that compound B is an example of a β-arrestin-biased PAM. Having both datasets in hand allows for a more complete understanding of the pharmacology of individual compounds.